[Clinical cooperative testing of the antidepressive agent noxiptilin in the University Neuroclinics of Kiel, Mainz and Marburg]. 1969

U Boeters, and H Grahmann, and N Petrilowitsch, and K Reckel, and U Spiegelberg

UI MeSH Term Description Entries
D006998 Hypochondriasis Preoccupation with the fear of having, or the idea that one has, a serious disease based on the person's misinterpretation of bodily symptoms. (APA, DSM-IV) Neurosis, Hypochondriacal,Hypochondriacal Neuroses,Hypochondriacal Neurosis
D008297 Male Males
D009497 Neurotic Disorders Disorders in which the symptoms are distressing to the individual and recognized by him or her as being unacceptable. Social relationships may be greatly affected but usually remain within acceptable limits. The disturbance is relatively enduring or recurrent without treatment. Neuroses,Psychoneuroses,Disorder, Neurotic,Disorders, Neurotic,Neurotic Disorder
D010259 Paranoid Disorders Chronic mental disorders in which there has been an insidious development of a permanent and unshakeable delusional system (persecutory delusions or delusions of jealousy), accompanied by preservation of clear and orderly thinking. Emotional responses and behavior are consistent with the delusional state. Paranoia,Paranoid Psychoses,Psychoses, Paranoid,Disorder, Paranoid,Disorders, Paranoid,Paranoias,Paranoid Disorder
D010554 Personality Disorders A major deviation from normal patterns of behavior. Avoidant Personality Disorder,Impulse-Ridden Personality,Inadequate Personality,Avoidant Personality Disorders,Impulse Ridden Personality,Personality Disorder,Personality Disorder, Avoidant,Personality Disorders, Avoidant,Personality, Impulse-Ridden,Personality, Inadequate
D002537 Intracranial Arteriosclerosis Vascular diseases characterized by thickening and hardening of the walls of ARTERIES inside the SKULL. There are three subtypes: (1) atherosclerosis with fatty deposits in the ARTERIAL INTIMA; (2) Monckeberg's sclerosis with calcium deposits in the media and (3) arteriolosclerosis involving the small caliber arteries. Clinical signs include HEADACHE; CONFUSION; transient blindness (AMAUROSIS FUGAX); speech impairment; and HEMIPARESIS. Cerebral Arteriosclerosis,Intracranial Atherosclerosis,Cerebral Atherosclerosis,Arterioscleroses, Cerebral,Arterioscleroses, Intracranial,Arteriosclerosis, Cerebral,Arteriosclerosis, Intracranial,Atheroscleroses, Cerebral,Atheroscleroses, Intracranial,Atherosclerosis, Cerebral,Atherosclerosis, Intracranial,Cerebral Arterioscleroses,Cerebral Atheroscleroses,Intracranial Arterioscleroses,Intracranial Atheroscleroses
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D003986 Dibenzocycloheptenes A family of tricyclic hydrocarbons whose members include many of the commonly used tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC).
D005076 Exanthema Diseases in which skin eruptions or rashes are a prominent manifestation. Classically, six such diseases were described with similar rashes; they were numbered in the order in which they were reported. Only the fourth (Duke's disease), fifth (ERYTHEMA INFECTIOSUM), and sixth (EXANTHEMA SUBITUM) numeric designations survive as occasional synonyms in current terminology. Rash,Skin Rash,Exanthem,Rash, Skin

Related Publications

U Boeters, and H Grahmann, and N Petrilowitsch, and K Reckel, and U Spiegelberg
July 1971, Die Medizinische Welt,
U Boeters, and H Grahmann, and N Petrilowitsch, and K Reckel, and U Spiegelberg
June 1969, Arzneimittel-Forschung,
U Boeters, and H Grahmann, and N Petrilowitsch, and K Reckel, and U Spiegelberg
January 1978, Psychiatria polska,
U Boeters, and H Grahmann, and N Petrilowitsch, and K Reckel, and U Spiegelberg
June 1969, Arzneimittel-Forschung,
U Boeters, and H Grahmann, and N Petrilowitsch, and K Reckel, and U Spiegelberg
June 1969, Arzneimittel-Forschung,
U Boeters, and H Grahmann, and N Petrilowitsch, and K Reckel, and U Spiegelberg
May 1971, Arzneimittel-Forschung,
U Boeters, and H Grahmann, and N Petrilowitsch, and K Reckel, and U Spiegelberg
May 1971, Arzneimittel-Forschung,
U Boeters, and H Grahmann, and N Petrilowitsch, and K Reckel, and U Spiegelberg
January 1982, Farmakologiia i toksikologiia,
U Boeters, and H Grahmann, and N Petrilowitsch, and K Reckel, and U Spiegelberg
October 1965, Hippokrates,
U Boeters, and H Grahmann, and N Petrilowitsch, and K Reckel, and U Spiegelberg
December 1968, Wiener klinische Wochenschrift,
Copied contents to your clipboard!